GlySens
Curated by SignalImplantable Continuous glucose monitoring device
Overview
GlySens Incorporated, a biomedical technology company, that develops implantable continuous glucose monitoring devices. Its device indicates the current blood glucose level, shows a historical chart of the previous blood glucose values, provides adjustable automatic warnings of high and low blood glucose readings, and stores. The GlySens fully implanted sensor demonstrated up to 18 month lifetime in preclinical testing, links wirelessly to an external receiver and provide continuous glucose measurement, recording, and alerts regarding hypo- and hyperglycemic glucose excursions.
Key facts
- Founded
- 1997
- Headquarters
- San Diego, United States
- Stage
- Sign up to view
- Industry
- High Technology
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view